| 3D Culture Method for Alzheimer's Disease Modeling Reveals Interleukin-4 Rescues Aβ42-Induced Loss of Human Neural Stem Cell Plasticity C Papadimitriou, H Celikkaya, MI Cosacak, V Mashkaryan, L Bray, ... Developmental cell 46 (1), 85-101. e8, 2018 | 136 | 2018 |
| Regulation of human dihydrofolate reductase activity and expression EE Abali, NE Skacel, H Celikkaya, YC Hsieh Vitamins & Hormones 79, 267-292, 2008 | 75 | 2008 |
| Stromal-based signatures for the classification of gastric cancer MT Uhlik, J Liu, BL Falcon, S Iyer, J Stewart, H Celikkaya, M O'Mahony, ... Cancer research 76 (9), 2573-2586, 2016 | 40 | 2016 |
| GATA3 promotes the neural progenitor state but not neurogenesis in primary human cortical astrocytes in 3D traumatic injury model H Celikkaya, MI Cosacak, P Bhattarai, S Popova, C Papadimitriou, ... Frontiers in Cellular Neuroscience 13, 23, 2019 | 27* | 2019 |
| mTOR inhibition leads to increased sensitivity to methotrexate G Saydam, H Celikkaya, P Cole, JR Bertino, EA Ercikan-Abali Cancer Research 65 (9 Supplement), 777-778, 2005 | 8 | 2005 |
| Immunization with UV-induced apoptotic cells generates monoclonal antibodies against proteins differentially expressed in hepatocellular carcinoma cell lines H Celikkaya, C Ciraci, E Oztas, ME Avci, M Ozturk, T Yagci Hybridoma 26 (2), 55-61, 2007 | 5 | 2007 |
| Three-Dimensional Biohybrid StarPEG–Heparin Hydrogel Cultures for Modeling Human Neuronal Development and Alzheimer’s Disease Pathology T Siddiqui, H Celikkaya, ZT Atasavum, S Popova, U Freudenberg, ... Alzheimer’s Disease, 159-170, 2023 | 3 | 2023 |
| Instructive starPEG-Heparin biohybrid 3D cultures for modeling human neural stem cell plasticity, neurogenesis, and neurodegeneration C Papadimitriou, MI Cosacak, V Mashkaryan, H Celikkaya, L Bray, ... bioRxiv, 225243, 2017 | 3 | 2017 |
| Interleukin-4 restores neurogenic plasticity of the primary human neural stem cells through suppression of Kynurenic acid production upon Amyloid-beta42 toxicity C Papadimitriou, H Celikkaya, MI Cosacak, V Mashkaryan, P Bhattarai, ... bioRxiv, 227306, 2017 | 2 | 2017 |
| Novel Therapeutic Approaches to Regulate Human Dihydrofolate Reductase Activity and Expression E Ercikan Abali, H Celikkaya, YC Hsieh, D Banerjee, J R Bertino Current enzyme inhibition 8 (2), 107-117, 2012 | 2 | 2012 |
| Modulation of dihydrofolate reductase expression using NAD analogues B Lawal, H Celikkaya, T Litvin-Vechnyak, J Bertino, EE Abali Cancer Research 67 (9 Supplement), 3192-3192, 2007 | 1 | 2007 |
| Modulation of antifolate sensitivity in cancer chemotherapy using mTOR inhibitors H Celikkaya, P Cole, J Bertino, EE Abali Cancer Research 67 (9 Supplement), 4763-4763, 2007 | 1 | 2007 |
| Novel antifolates that do not upregulate thymidylate synthase and dihydrofolate reductase levels H Celikkaya, HD Jain, Y Zeng, J Yang, X Lin, A Gangjee, JR Bertino, ... Cancer Research 66 (8 Supplement), 131-131, 2006 | 1 | 2006 |
| Modulation of Antifolate Sensitivity in Cancer Chemotherapy H Celikkaya Celikkaya, 2007 | | 2007 |
